MAPT and frontotemporal dementia: Inhibition of PERK by the oral administration of a PERK inhibitor, GSK2606414 in a transgenic mouse model of Fronto Temporal Dementia (FTD) prevented tau-mediated neurodegeneration (Radford et al., 2015).